Evidence map›Paper›PMID 37333399›Full record

ArticlemedRxiv : the preprint server for health sciences2023

Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study.

Michiel van Boven, Christiaan H van Dorp, Ilse Westerhof, Vincent Jaddoe, Valerie Heuvelman, Liesbeth Duijts, Elandri Fourie, Judith Sluiter-Post, Marlies A van Houten, Paul Badoux and 11 more

Open access · greenAbstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 3 countries.

Michiel van BovenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Christiaan H van DorpDepartment of Pathology & Cell Biology, Columbia University Irving Medical Center, New York, United States.
Ilse WesterhofJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Vincent JaddoeErasmus Medical Center, Rotterdam, the Netherlands.
Valerie HeuvelmanErasmus Medical Center, Rotterdam, the Netherlands.
Liesbeth DuijtsErasmus Medical Center, Rotterdam, the Netherlands.
Elandri FourieSpaarne Gasthuis, Hoofddorp, the Netherlands.
Judith Sluiter-PostSpaarne Gasthuis, Hoofddorp, the Netherlands.
Marlies A van HoutenSpaarne Gasthuis, Hoofddorp, the Netherlands.
Paul BadouxRegional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Sjoerd EuserRegional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Bjorn HerpersRegional Public Health Laboratory Kennemerland, Haarlem, the Netherlands.
Dirk EgginkNational Institute for Public Health, and the Environment, Bilthoven, the Netherlands.
Marieke de HoogJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Trisja BoomJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Joanne WildenbeestDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's hospital, University Medical Center Utrecht, the Netherlands.
Louis BontDepartment of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's hospital, University Medical Center Utrecht, the Netherlands.
Ganna RozhnovJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Marc J BontenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Mirjam E KretzschmarJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Patricia Bruijning-VerhagenJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.
Utrecht University · NLErasmus MC · NLSpaarne Gasthuis · NLSpaarne Ziekenhuis · NLUniversity Medical Center · USColumbia University Irving Medical Center · USNational Institute for Public Health and the Environment · NLUniversity of Lisbon · PT

Funding

Viral dynamics of rebound and control following early treatment of HIV/SIVP01AI131365 · NIAID · BOSTON COLLEGE · PI WHITNEY, JAMES BURTON · 2017 to 2021
$7.5M
Modeling Viral and T Lymphocyte DynamicsR01OD011095 · OD · TRIAD NATIONAL SECURITY, LLC · PI PERELSON, ALAN S · 2012 to 2024
$5.0M
NIAID NIH HHS P01 AI131365NIH HHS R01 OD011095
6 · The paper itself

Abstract

Household studies provide an efficient means to study transmission of infectious diseases, enabling estimation of individual susceptibility and infectivity. A main inclusion criterion in such studies is often the presence of an infected person. This precludes estimation of the hazards of pathogen introduction into the household. Here we use data from a prospective household-based study to estimate SARS-CoV-2 age- and time-dependent household introduction hazards together with within household transmission rates in the Netherlands from August 2020 to August 2021. Introduction hazards and within-household transmission rates are estimated with penalized splines and stochastic epidemic models, respectively. The estimated hazard of introduction of SARS-CoV-2 in the households was lower for children (0-12 years) than for adults (relative hazard: 0.62; 95%CrI: 0.34-1.0). Estimated introduction hazards peaked in mid October 2020, mid December 2020, and mid April 2021, preceding peaks in hospital admissions by 1-2 weeks. The best fitting transmission models include increased infectivity of children relative to adults and adolescents, such that the estimated child-to-child transmission probability (0.62; 95%CrI: 0.40-0.81) was considerably higher than the adult-to-adult transmission probability (0.12; 95%CrI: 0.057-0.19). Scenario analyses show that vaccination of adults could have strongly reduced infection attack rates in households and that adding adolescent vaccination would have offered limited added benefit.

Identifiers

PMID37333399
PMCPMC10275010
OpenAlexW4379377571

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.